Advanced Search

Study Preview



Study Title and Description

Sofosbuvir in combination with daclatasvir or simeprevir for 12 weeks in noncirrhotic subjects chronically infected with hepatitis C virus genotype 1: a randomized clinical trial.



Key Questions Addressed
6 Key Question 6. What is the effectiveness of currently recommended antiviral treatments in improving health outcomes in patients with HCV infection?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Sofosbuvir in combination with daclatasvir or simeprevir for 12 weeks in noncirrhotic subjects chronically infected with hepatitis C virus genotype 1: a randomized clinical trial.
Author Pott-Junior H., Bricks G., Grandi G., Figueiredo Senise J., Castelo Filho A.
Country Division of Infectious Diseases, Federal University of São Paulo, São Paulo, Brazil. Electronic address: henriquepott@gmail.com.
Year 2019
Numbers Pubmed ID: 29906601

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-9


Results & Comparisons

No Results found.